Combination comprising paclitaxel for treating ovarian cancer

Details for Australian Patent Application No. 2009215329 (hide)

Owner ACTELION PHARMACEUTICALS LTD

Inventors Regenass, Urs; Clozel, Martine

Agent A J Park

Pub. Number AU-A-2009215329

PCT Pub. Number WO2009/104149

Priority PCT/ IB2008/050607 20.02.08 IB

Filing date 19 February 2009

Wipo publication date 27 August 2009

International Classifications

A61K 31/216 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/104149 Priority application(s): WO2009/104149

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215336-Electrode element, method of manufacturing electrode element, and lithium ion secondary battery

2009215327-Azatricyclic antibiotic compounds